Edition:
United States

Boiron SA (BOIR.PA)

BOIR.PA on Paris Stock Exchange

69.00EUR
20 Jul 2018
Change (% chg)

€-3.80 (-5.22%)
Prev Close
€72.80
Open
€71.10
Day's High
€71.30
Day's Low
€68.50
Volume
17,566
Avg. Vol
6,426
52-wk High
€85.00
52-wk Low
€66.10

Chart for

About

Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy... (more)

Overall

Beta: 0.93
Market Cap(Mil.): €1,411.45
Shares Outstanding(Mil.): 19.41
Dividend: 1.60
Yield (%): 2.20

Financials

  BOIR.PA Industry Sector
P/E (TTM): 17.15 28.87 33.05
EPS (TTM): 4.25 -- --
ROI: 12.61 13.59 13.17
ROE: 15.85 15.31 15.10

French and Benelux stocks-Factors to watch on April 27

April 27 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

Apr 27 2018

BRIEF-Boiron Q1 Revenue Broadly Stable At 159.4 Million Euros

* TURNOVER IN Q1 OF 2018 IS ALMOST STABLE (-0.5%) IN COMPARISON TO Q1 OF 2017

Apr 26 2018

BRIEF-Boiron FY Operating Income Down At 125.0 ‍​Million Euros

* FY OPERATING INCOME EUR 125.0 ‍​ MILLION VERSUS EUR 129.7 MILLION YEAR AGO

Mar 14 2018

BRIEF-Boiron FY Revenue up at 617.5 Million Euros

* FY REVENUE EUR 617.5 MILLION VERSUS EUR 614.5 MILLION YEAR AGO

Jan 25 2018

Earnings vs. Estimates